News & Trends - MedTech & Diagnostics
Focus on mental health welcomed by Australian Private Hospitals Association
The Australian Private Hospitals Association (APHA) has welcomed the federal government’s first Deputy Chief Medical Officer role with a focus on mental health during COVID-19.
APHA CEO Michael Roff congratulated Associate Professor Ruth Vine on her appointment.
“APHA will work collaboratively with the Associate Professor Vine to promote good mental health care in Australia. Private psychiatric hospitals provide important care to Australians, particularly in the most prevalent mental health disorders – anxiety and depression.
“Private hospitals have entered into agreements with the Federal and State/Territory Governments to meet the challenge of the COVID-19 pandemic. As experts are predicting a considerable uptick in mental health stressors for Australians as a result of the pandemic, the services provided by private mental health facilities will be essential,” he said.
Mr Roff said Australians were now able to access a once-in-a-lifetime, immediate upgrade of their private health insurance to access private psychiatric hospital care should they need it. Affordable access to quality mental health care is a key challenge right now, which is why the immediate upgrade is such an important measure.
“We also have to recognise that a lot of people who need care now don’t have private health insurance – so public and private sectors, Commonwealth and States need to work together,” he said.
In alignment with the Federal Government’s mental health initiative the #SelfcareInHealthcare campaign has been launched to encourage Pharma, Biotech and MedTech industry professionals to take action on mental health during COVID-19. Follow the LinkedIn page and share with 8 people in your network.
Digital & Innovation
Cybersecurity tops investment priorities for ANZ companies
Digital & Innovation: Cybersecurity remains the top technology investment for Australian and New Zealand (ANZ) companies, with a striking 88% […]
MoreNews & Trends - Pharmaceuticals
Novo Nordisk and Lilly’s GLP-1 agonists show promise in type 1 diabetes
Pharma News: GLP-1 receptor agonists lead to significant weight loss and improve blood sugar control in individuals with type 1 […]
MoreNews & Trends - MedTech & Diagnostics
Health Department’s proposed reporting rules face industry pushback over costs and confidentiality
MedTech News: The Department of Health has unveiled stakeholder feedback on the reporting requirements for the Prescribed List (PL), sparking […]
MoreNews & Trends - MedTech & Diagnostics
Threat to innovation: Health Department’s PL reforms spark industry backlash
MedTech News: The Department of Health has unveiled stakeholder feedback on the alignment of charges for supplying medical devices with […]
More